2
Insulin: recent developments with portable infusion pumps Retinal function after 2 years of continuous subcutaneous insulin infusion (CSIJ) in patients with background retinopathy. Lauritzen, T. et al.: International Journal of Artificial Organs 6: 164 (1983) EITect of 12 months continuous subcutaneous insulin infusion (CSII) treatment on diabetic neuropathy and retinopathy. Massibenedetti, M. et al.: International Journal of Artificial Organs 6: 165 (1983) Long term treatment with CIIS in diabetic outpatients - technical and patient problems. Kashiwagi, S. et al.: International Journal of Artificial Organs 6: 165 (1983) Continuously monitored diurnal blood glucose levels in pump treated diabetic patients. Arias, P. et al.: International Journal of Artificial Organs 6: 160 (1983) Short and long-term continuous subcutaneous insulin infusion (CSII) in patients with diabetic autonomic neuropathy (DAN). Bellavere, F. et al.: International Journal of Artificial Organs 6: 160 (1983) The use of insulin pumps in pregnancy. Hofmann, H. et al.: International Journal of Artificial Organs 6: 160 (1983) Clinical evaluation of a new insulin infusion pump - CSII for up to 4 months. Bending, JJ . et al.: International Journal of Artificial Organs 6: 161 (1983) Open loop device microjet MC2 improves unstable diabetes, lowers the daily insulin requirement and reduces the excursions of plasma free insulin levels; comparison with a traditional intensive treatment. Micossi, P. et al.: Journal of Endocrinological Investigation 6: 189 (1983) Insulin pump treatment of diabetes. Felig, P. and Bergman, M.: Journal of the American Medical Association 250: 1045 (1983) Metabolic elTect of long-term continuous subcutaneous insulin infusion (CSII). Massi. M. et al.: Diabetes 32 (Suppl. I): 170A (1983) Use of the insulin pump (IP) in the diabetic surgical patient. Kossover, M.F. and Kossover. J.J .: Diabetes 32 (Suppl. I): 171 A (1983) Early-morning hyperglycemia in diabetic individuals treated with continuous subcutaneous insulin infusion. GeITner, M.E. et al.: Diabetes Care 6: 129 (1983) Open-loop intravenous insulin waveforms for postprandial exercise in type-I diabetes. Poussier, P. et al.: Diabetes Care 6: 129 (1983) Exercise in insulin-dependent diabetes mellitus the elTect of continuous insulin infusion using the subcutaneous, intravenous and intraperitoneal sites. Gooch. B.R. et al.: Diabetes Care 6: 122 (1983) Long-term ambulatory peritoneal insulin infusion of brittle diabetes with portable pumps - comparison with intravenous and subcutaneous routes. Selam, J.L. et al.: Diabetes Care 6: 105 (1983) CSII and leT in treating type-I diabetic individuals. Georgopoulos, A.: Diabetes Care 6: 210 (1983) How to choose an insulin pump. leBlanc, H.: Diabete and Metabolisme 10: 223 (1984) External and implantable pumps for continuous drug delivery. Gibaldi, M. : Perspective in Pharmacology 2: 57 (1984) Insulin pumps - still a research tool? Lauritzen, T. and Pra-ming, S.: Annals of Clinical Research 16: 98 (1984) Treatment with insulin pumps versus intensive conventional treatment. Bending, J.J. et al.: British Medical Journal 289: 320 (1984) Artificial devices for continuous insulin administration; an outlook. Micossi. P. et al.: International Journal of Artificial Organs 7: I (1984) Continuous single-rate long-term insulin infusion using a totally implantable plant. Chute, E.P. et al.: Transactions American Society Artificial Internal Organs 30: 387 (1984) Insulin pump therapy: rationale and principles of use. Horwitz, D.L.: Postgraduate Medicine 76: 80 (1984) Use of continuous insulin infusion therapy to achieve improved 0156-2703/85/ 0720-0019/0$01.00/0 © ADIS Press metabolic control. Chiumello, G. et al.: Panminerva Medica 26: 171 (1984) Continuous insulin therapy by pump in children and adolescents. Fashion or progress? Jean, R. et al.: Archives de Pediatrie 41 : 595 (1984) A semi-closed loop computer-assisted insulin infusion system. Chisholm, D.J. et al.: Medical Journal of Australia 141: 784 (1984) External and implantable pumps for continuous drug delivery. Gibaldi, M.: Perspective in Clinical Pharmacology 2: 57 (1984) Ambulatory infusion of insulin in diabetes with portable pumps. Leblanc, H. et al.: Gazette Medicale 91: 29 (1984) Insulin pump therapy improves blood glucose control during hyperalimentation. Bergman, M. et al.: Archives of Internal Medicine 144: 2013 (1984) Continuous subcutaneous insulin infusion (Mill-hill infuser) versus multiple injections (Medijector) in the treatment of insulin- dependent diabetes mellitus and the effect of metabolic control on microangiopathy. Chiasson, J. L. et al.: Diabetes Care 7: 331 (1984) Continuous subcutaneous insulin infusion and postprandial exercise in tightly controlled type-I (insulin-dependent) diabetic patients. Trovati, M. et al.: Diabetes Care 7: 327 (1984) Insulin infusion pump treatment of type I diabetes. Tamborlane, W.V. and Press, C.M.: Pediatric Clinics of North America 31: 721 (1984) Characterization of diabetic patients resistant to pump treatment (CSII). Micossi, P. et al.: Diabetes 33 (Suppl. I): 177 A (1984) Beneficial elTect of elTective insulin therapy with pumps on non- ischemic forms of diabetic retinopathy. Mirouze, J. et a\.: Diabetes 33 (Suppl. I): 182A (1984) How to achieve a successful outpatient insulin pump program for brittle diabetics. Biby, C. et al.: Diabetes 33 (Suppl. I): 123A (1984) Determination of daily insulin dose by biostator and subcutaneous insulin infusion pump (SlIP) versus conventional method. Garg, A. et al.: Diabetes 33 (Suppl. I): 107 A (1984) Diabetic ketoacidosis (DKA) in infants: clinical presentation and response to continuous intravenous insulin therapy (CIIT). Abbassi, V. and Razi. I.: Diabetes 33 (Suppl. I): I02A (1984) Successful fixed rate intravenous insulin pump therapy in three insulin resistant diabetic patients. Chute, E.P. et al.: Diabetes 33 (Suppl. I): 86A (1984) Rarity of the dawn phenomenon in diabetics treated by continuous subcutaneous insulin infusion (CSII). Bending, J.J. et al.: Diabetes 33 (Suppl. I) : 85A (1984) Blockage and leakage of infusion sets causing loss of biabetes control in patients using continuous subcutaneous insulin infusion (CSII). Sannar, C. et al.: Diabetes 33 (Suppl. I): 74A (1984) Long-term treatment with external and implanted insulin infusion devices. Irsigler, K. et al.: Diabetes 33 (Suppl. I): 73A (1984) The use of continuous subcutaneous insulin infusion pumps in 10 states. Teutsch. S. and Herman, W.: Diabetes 33 (Suppl. I): 73A (1984) Randomized trial of continuous subcutaneous insulin infusion versus intensive conventional insulin therapy in pregnant diabetics. Coustan, D.R. et al.: Diabetes 33 (Suppl. I): 23A (1984) Insulin pump therapy in infants with type I diabetes. Bougneres, P.F. et al.: Diabetes 33(Suppl. I): 22A (1984) Insulin pump therapy in young children with type I diabetes. Bougneres, P.F. et al.: Journal of Pediatrics 105: 212 (1984) Trial of a 100 Ujml insulin peritoneal infusion administered with a portable pump. Selam, J.L. et al.: Presse Medicale 13: 1339 (1984) Continuous subcutaneous insulin infusion and propranolol-induced hypoglycemia in a brittle diabetic patient. Sotaniemi, E.A. et al.: Diabetes Care 7: 305 (1984) Continuous subcutaneous insulin infusion: the insulin pump. De Nobel, E.: Netherlands Journal of Medicine 27: 173 (1984) INPHARMA" 20 Ju11985 19

Insulin: recent developments with portable infusion pumps

  • Upload
    lykiet

  • View
    214

  • Download
    2

Embed Size (px)

Citation preview

Page 1: Insulin: recent developments with portable infusion pumps

Insulin: recent developments with portable infusion pumps

Retinal function after 2 years of continuous subcutaneous insulin infusion (CSIJ) in patients with background retinopathy. Lauritzen, T. et al.: International Journal of Artificial Organs 6: 164 (1983)

EITect of 12 months continuous subcutaneous insulin infusion (CSII) treatment on diabetic neuropathy and retinopathy. Massibenedetti, M. et al.: International Journal of Artificial Organs 6: 165 (1983)

Long term treatment with CIIS in diabetic outpatients - technical and patient problems. Kashiwagi, S. et al.: International Journal of Artificial Organs 6: 165 (1983)

Continuously monitored diurnal blood glucose levels in pump treated diabetic patients. Arias, P. et al.: International Journal of Artificial Organs 6: 160 (1983)

Short and long-term continuous subcutaneous insulin infusion (CSII) in patients with diabetic autonomic neuropathy (DAN). Bellavere, F. et al.: International Journal of Artificial Organs 6: 160 (1983)

The use of insulin pumps in pregnancy. Hofmann, H. et al.: International Journal of Artificial Organs 6: 160 (1983)

Clinical evaluation of a new insulin infusion pump - CSII for up to 4 months. Bending, JJ. et al.: International Journal of Artificial Organs 6: 161 (1983)

Open loop device microjet MC2 improves unstable diabetes, lowers the daily insulin requirement and reduces the excursions of plasma free insulin levels; comparison with a traditional intensive treatment. Micossi, P. et al.: Journal of Endocrinological Investigation 6: 189 (1983)

Insulin pump treatment of diabetes. Felig, P. and Bergman, M.: Journal of the American Medical Association 250: 1045 (1983)

Metabolic elTect of long-term continuous subcutaneous insulin infusion (CSII). Massi. M. et al.: Diabetes 32 (Suppl. I): 170A (1983)

Use of the insulin pump (IP) in the diabetic surgical patient. Kossover, M.F. and Kossover. J.J .: Diabetes 32 (Suppl. I): 171 A (1983)

Early-morning hyperglycemia in diabetic individuals treated with continuous subcutaneous insulin infusion. GeITner, M.E. et al.: Diabetes Care 6: 129 (1983)

Open-loop intravenous insulin waveforms for postprandial exercise in type-I diabetes. Poussier, P. et al.: Diabetes Care 6: 129 (1983)

Exercise in insulin-dependent diabetes mellitus the elTect of continuous insulin infusion using the subcutaneous, intravenous and intraperitoneal sites. Gooch. B.R. et al.: Diabetes Care 6: 122 (1983)

Long-term ambulatory peritoneal insulin infusion of brittle diabetes with portable pumps - comparison with intravenous and subcutaneous routes. Selam, J.L. et al.: Diabetes Care 6: 105 (1983)

CSII and leT in treating type-I diabetic individuals. Georgopoulos, A.: Diabetes Care 6: 210 (1983)

How to choose an insulin pump. leBlanc, H.: Diabete and Metabolisme 10: 223 (1984)

External and implantable pumps for continuous drug delivery. Gibaldi, M.: Perspective in Clini~1 Pharmacology 2: 57 (1984)

Insulin pumps - still a research tool? Lauritzen, T. and Pra-ming, S.: Annals of Clinical Research 16: 98 (1984)

Treatment with insulin pumps versus intensive conventional treatment. Bending, J.J. et al.: British Medical Journal 289: 320 (1984)

Artificial devices for continuous insulin administration; an outlook. Micossi. P. et al.: International Journal of Artificial Organs 7: I (1984)

Continuous single-rate long-term insulin infusion using a totally implantable plant. Chute, E.P. et al.: Transactions American Society Artificial Internal Organs 30: 387 (1984)

Insulin pump therapy: rationale and principles of use. Horwitz, D.L.: Postgraduate Medicine 76: 80 (1984)

Use of continuous insulin infusion therapy to achieve improved

0156-2703/85/ 0720-0019/0$01.00/0 © ADIS Press

metabolic control. Chiumello, G. et al.: Panminerva Medica 26: 171 (1984)

Continuous insulin therapy by pump in children and adolescents. Fashion or progress? Jean, R. et al.: Archives Fran~aises de Pediatrie 41 : 595 (1984)

A semi-closed loop computer-assisted insulin infusion system. Chisholm, D.J. et al.: Medical Journal of Australia 141: 784 (1984)

External and implantable pumps for continuous drug delivery. Gibaldi, M.: Perspective in Clinical Pharmacology 2: 57 (1984)

Ambulatory infusion of insulin in diabetes with portable pumps. Leblanc, H. et al.: Gazette Medicale 91: 29 (1984)

Insulin pump therapy improves blood glucose control during hyperalimentation. Bergman, M. et al.: Archives of Internal Medicine 144: 2013 (1984)

Continuous subcutaneous insulin infusion (Mill-hill infuser) versus multiple injections (Medijector) in the treatment of insulin­dependent diabetes mellitus and the effect of metabolic control on microangiopathy. Chiasson, J.L. et al.: Diabetes Care 7: 331 (1984)

Continuous subcutaneous insulin infusion and postprandial exercise in tightly controlled type-I (insulin-dependent) diabetic patients. Trovati, M. et al.: Diabetes Care 7: 327 (1984)

Insulin infusion pump treatment of type I diabetes. Tamborlane, W.V. and Press, C.M.: Pediatric Clinics of North America 31: 721 (1984)

Characterization of diabetic patients resistant to pump treatment (CSII). Micossi, P. et al.: Diabetes 33 (Suppl. I): 177 A (1984)

Beneficial elTect of elTective insulin therapy with pumps on non­ischemic forms of diabetic retinopathy. Mirouze, J. et a\.: Diabetes 33 (Suppl. I): 182A (1984)

How to achieve a successful outpatient insulin pump program for brittle diabetics. Biby, C. et al.: Diabetes 33 (Suppl. I): 123A (1984)

Determination of daily insulin dose by biostator and subcutaneous insulin infusion pump (SlIP) versus conventional method. Garg, A. et al.: Diabetes 33 (Suppl. I): 107 A (1984)

Diabetic ketoacidosis (DKA) in infants: clinical presentation and response to continuous intravenous insulin therapy (CIIT). Abbassi, V. and Razi. I.: Diabetes 33 (Suppl. I): I02A (1984)

Successful fixed rate intravenous insulin pump therapy in three insulin resistant diabetic patients. Chute, E.P. et al.: Diabetes 33 (Suppl. I): 86A (1984)

Rarity of the dawn phenomenon in diabetics treated by continuous subcutaneous insulin infusion (CSII). Bending, J.J. et al.: Diabetes 33 (Suppl. I): 85A (1984)

Blockage and leakage of infusion sets causing loss of biabetes control in patients using continuous subcutaneous insulin infusion (CSII). Sannar, C. et al.: Diabetes 33 (Suppl. I): 74A (1984)

Long-term treatment with external and implanted insulin infusion devices. Irsigler, K. et al.: Diabetes 33 (Suppl. I): 73A (1984)

The use of continuous subcutaneous insulin infusion pumps in 10 states. Teutsch. S. and Herman, W.: Diabetes 33 (Suppl. I): 73A (1984)

Randomized trial of continuous subcutaneous insulin infusion versus intensive conventional insulin therapy in pregnant diabetics. Coustan, D.R. et al.: Diabetes 33 (Suppl. I): 23A (1984)

Insulin pump therapy in infants with type I diabetes. Bougneres, P.F. et al.: Diabetes 33(Suppl. I): 22A (1984)

Insulin pump therapy in young children with type I diabetes. Bougneres, P.F. et al.: Journal of Pediatrics 105: 212 (1984)

Trial of a 100 Ujml insulin peritoneal infusion administered with a portable pump. Selam, J.L. et al.: Presse Medicale 13: 1339 (1984)

Continuous subcutaneous insulin infusion and propranolol-induced hypoglycemia in a brittle diabetic patient. Sotaniemi, E.A. et al.: Diabetes Care 7: 305 (1984)

Continuous subcutaneous insulin infusion: the insulin pump. De Nobel, E.: Netherlands Journal of Medicine 27: 173 (1984)

INPHARMA" 20 Ju11985 19

Page 2: Insulin: recent developments with portable infusion pumps

Insulin pumps: choice and management. De Nobel, E. : Netherlands Journal of Medicine 27: 193 (1984)

Feasibility and efficacy of long term treatment by continuous subcutaneous insulin infusion (CSIJ) in insulin-dependent diabetes. Van Ballegooie, E. et al.: Netherlands Journal of Medicine 27: 185 (1984)

Continuous subcutaneous insulin infusion in the ambulatory management of young diabetics. Bougneres, P.F. et al. : Archives Fran~aises de Pediatrie 41: 27 (1984)

Insulin pumps - the patients verdict. Fredholm, N. et aI. : American Journal of Nursing 84: 36 (1984)

Insulin pumps and other recent advances in the outpatient treatment of diabetes. Loewenstein, J.E.: Archives ofinternal Medicine 144: 755 (1984)

Reversal of insulin resistance in type I diabetes after treatment with continuous subcutaneous insulin infusion. Pickup, J.e. et al.: British Medical Journal 288: 796 (1984)

Metabolic control in newly diagnosed type 1 diabetic children. Effect of continuous subcutaneous infusion. d'Arcais, F. et al. : Hormone Research 19: 65 (1984)

Acute mishaps during insulin pump treatment. Lancet 1: 911 (1985) Insulin pumps and other recent advances with insulin delivery in the

treatment of diabetes mellitus. Scott, R.S.: New Zealand Medical 10urnal 98: 485 (1985)

Incidence of hypoglycemic episodes in diabetic patients under continuous subcutaneous insulin infusion and intensified conventional insulin treatment - assessment by means of semiambulatory 24-hour continuous blood glucose monitoring. Arias, P. et al.: Diabetes Care 8: 134 (1985)

Dietary practices of persons with diabetes during insulin pump therapy. Capper, A.F. et al.: Journal of the American Dietetic Association 85: 445 (1985)